#DYK that 4 in 10 Canadians do not understand #HeartFailure? Heart attacks, high blood pressure and other issues can all lead to HF, a chronic condition with no cure but plenty of hope and strength ➡️ @heartandstroke https://t.co/YFa09GnkQk #CardioTwitter https://t.co/4g5QD8pvpx

Rejoignez-nous pour un webinaire en direct! Relevez haut la main les défis cliniques de l’aggravation de l’IC, et de l’ATTR Mercredi, 23 November 2022 19 h à 20 h https://t.co/zPYEFnLooz https://t.co/INJL09Ga2t

Treating patients with #heartfailure who aren’t responding to GDMT? Here’s why you may want to send them to an electrophysiologist for device implantation: https://t.co/R6SanWh1v7 #Cardiology #CardioTwitter

Worsening Heart Failure with Dr. Anique Ducharme & Dr. @justinezekowitz: Dec. 5 @ 7pm Register now: https://t.co/RMMeEpboTN #heartfailure #cardiotwitter https://t.co/KxnhzYik8E

Webinar Alert ? The New HF Frontier invites you to not one, but TWO upcoming webinars: ATTR Amyloidosis with Dr. Nowell Fine & Dr. Lisa Mielniczuk: Thursday, Nov. 24 @ 7pm Register now: https://t.co/RMMeEpboTN #heartfailure #CardioTwitter https://t.co/X1VDnHNbiZ

La SCIC @CanHFSociety vous invite à un webinaire en direct avec Dr @AniqueDucharme, et Dr Francois Tournoux le 23 novembre. RSVP à https://t.co/XpWf2HyfOx https://t.co/mJGoX7dRbh

How Can SGLT2i Stimulate Erythrocytosis in Patients Who Are #Iron Deficient? Understanding Iron Hemostasis in #HeartFailure ✅ Another great review by Prof Milton Packer @ESC_Journals SGLT2i ⬆️ cytosolic Fe2+ available to mitochondria —> ⬆️ mitochondrial ATP in the ? https://t.co/xOVhmRIy15

Effects of #Empagliflozin on #Erythropoiesis in #HeartFailure: Data from the Empire HF Trial suggests the cardioprotective properties of empagliflozin which increases erythropoiesis and augments early iron utilization in patients with #HFrEF @ESC_Journals #EJHF https://t.co/lPR722S5Xb

Additionally, he is involved with numerous organizations such as @SCC_CCS, @CanHFSociety, @HeartandStroke, @CIHR_IRSC, @HFSA, @escardio, @ACCinTouch & @american_heart. Welcome Dr. Ezekowitz @JustinEzekowitz - we are so excited to have you at our helm! #CardioTwitter

➡️Join the expert panel from the comfort?of your home as they discuss: ?RAASi therapy dosing in the treatment of #HeartFailure ?#Hyperkalemia as a barrier to optimal #RAASi therapy ?#DIAMOND trial @CanHFSociety @JustinEzekowitz @ShelleyZieroth @JavedButler1 #CardioTwitter https://t.co/hC0hu02P4t